Cornercap Investment Counsel Inc Lian Bio Transaction History

Cornercap Investment Counsel Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$1.49 - $2.46 $1,785 - $2,947	-1,198 Reduced 1.17%	101,039 $150,000
Q2 2023 Aug 11, 2023	SELL	$1.79 - $2.85 $113,061 - $180,014	-63,163 Reduced 38.19%	102,237 $233,000
Q1 2023 May 11, 2023	SELL	$1.57 - $2.66 $499 - $845	-318 Reduced 0.19%	165,400 $324,000
Q4 2022 Feb 13, 2023	BUY	$1.14 - $2.11 $95,632 - $177,003	83,888 Added 102.51%	165,718 $271,000
Q3 2022 Nov 14, 2022	BUY	$1.87 - $3.0 $55,520 - $89,070	29,690 Added 56.94%	81,830 $163,000
Q2 2022 Aug 15, 2022	BUY	$2.15 - $6.01 $112,101 - $313,361	52,140 New	52,140 $113,000

1.1M

Ticker LIAN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 108,354,000
Market Cap $32.5M
Description
LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, respiratory, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with p...

Get notified when there are updates to the investment portfolio of Cornercap Investment Counsel Inc, based on Form 13F filings with the SEC.

Stay updated on Cornercap Investment Counsel Inc with notifications on news.